Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- QD -2.1%
Other news:
- NVO -9.8% (Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression)
- OWLT -9% (files for 5,346,194 share common stock offering by selling shareholders)
- TNXP -3.5% (announces FDA IND clearance for phase 2 study of TNX-102 SL for the treatment of major depressive disorder)
- NNOX -3% (enters direct offering of common stock for gross proceeds of ~$15 mln)
- PFGC -2.7% (Performance Food Group & and US Foods (USFD) terminate information sharing process and will no longer pursue a potential business combination between the two companies; both cos reaffirm guidance)
- LODE -2.4% (files for $200 mln mixed securities shelf offering; receives notification of eligibility for final permit)
- CCCC -1.2% (files for $400 mln mixed securities shelf offering)
- SCLX -1.2% (announces $20.3 mln in gross proceeds from warrant exercises)
- BHP -0.8% (BHP Group issues statement regarding proposal for Anglo American (NGLOY); BHP confirms that it is no longer considering a combination of the two companies)